Bibliographic Details
| Title: |
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. |
| Authors: |
Fabian CJ; University of Kansas Medical Center, Kansas City, Kansas 66160, USA. cfabian@kumc.edu, Kimler BF, Anderson J, Tawfik OW, Mayo MS, Burak WE Jr, O'Shaughnessy JA, Albain KS, Hyams DM, Budd GT, Ganz PA, Sauter ER, Beenken SW, Grizzle WE, Fruehauf JP, Arneson DW, Bacus JW, Lagios MD, Johnson KA, Browne D |
| Source: |
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2004 Aug 15; Vol. 10 (16), pp. 5403-17. |
| Publication Type: |
Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
